Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Health Economics|September 24, 2004
Modelling EuroQol health-related utility values for diabetic complications from CODE-2 dataAdrian Bagust, Sophie BealeMedical Decision Making : an International Journal of the Society for Medical Decision Making|August 1, 2013
Survival analysis and extrapolation modeling of time-to-event clinical trial data for economic evaluation: an alternative approachAdrian Bagust, Sophie BealeHealth Technology Assessment (Winchester, England)|July 2, 2015
A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in childrenSophie Beale, Diana Sanderson, Anna Sanniti, et al.Pharmacoeconomics|June 28, 2006
Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UKSophie Beale, Adrian Bagust, Arran T Shearer, et al.Pharmacoeconomics|June 28, 2006
A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategiesAdrian Bagust, Marc Evans, Sophie Beale, et al.Pharmacoeconomics|August 21, 2014
Pertuzumab in combination with trastuzumab and docetaxel for the treatment of HER2-positive metastatic or locally recurrent unresectable breast cancerNigel Fleeman, Adrian Bagust, Sophie Beale, et al.Health Technology Assessment (Winchester, England)|June 29, 2026
Digital front door technologies to pre-assess people before assessment for NHS Talking Therapies [HTE10055]: early value assessmentNigel Fleeman, James Mahon, Samuel Bryning, et al.Health Technology Assessment (Winchester, England)|October 29, 2015
The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluationAmanda Nicholson, James Mahon, Angela Boland, et al.Health Technology Assessment (Winchester, England)|June 27, 2020
Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluationJuliet Hounsome, Gerlinde Pilkington, James Mahon, et al.BMC Cancer|December 14, 2019
A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodineNigel Fleeman, Rachel Houten, Marty Chaplin, et al.Pageof 4